US proposes to make COVID-19 shot annual, much like flu shot
Jan 24, 2023
The FDA also wants to switch all COVID-19 vaccines to target the same strains, making the shots interchangeable and simpler to administer.
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Apr 30, 2024
The findings compared with placebo at 28-day and 43-day follow-up.
COVID-19 boosters targeted to latest variants could be ready after Labor Day
Aug 24, 2022
Both Moderna and Pfizer filed their applications for emergency use of their updated boosters this week.
Positive link identified between SARS-CoV-2 and Guillain-Barré
Oct 18, 2023
Odds ratio of 6.30 for Guillain-Barré syndrome association with SARS-CoV-2 infection and 0.41 for COVID-19 vaccine administration.
Updated booster shots, not original COVID-19 vaccines, should be standard: FDA panel
Jan 27, 2023
Committee members also weighed a proposal to streamline the dosing schedule for COVID-19 vaccines by turning them into annual shots.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
More news for Monday, May 22
By
Kimberly Bonvissuto
May 22, 2023
LeadingAge, HHS collaboration leads to 39 vaccine clinics in senior living, other settings … Christian Living Communities unveils new website … Senators ask FTC for answers on protecting seniors from...
More news for Friday, May 5
By
Kimberly Bonvissuto
May 05, 2023
Season of Reflection is 2023 theme for National Assisted Living Week … Most older adults say they will get updated COVID-19 booster, but will they? … First-ever RSV vaccine gets FDA nod, approved for...
CDC may recommend COVID boosters for some this spring
Feb 16, 2024
The panel is expected to focus on the safety of high-risk Americans, including people 65 and older and anyone with a weakened immune system.
Booster cuts COVID-19-related mortality in adults with chronic conditions
Jan 30, 2023
The findings “support the recent focus on older people and those with chronic conditions for future booster doses of SARS-CoV-2 vaccines beyond the first booster,” the authors write.